Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 40, Issue 1, Pages 221-226Publisher
IOS PRESS
DOI: 10.3233/JAD-131850
Keywords
Alzheimer's disease; dementia; institutionalization; longitudinal; nursing home; survival analysis
Categories
Funding
- National Health and Medical Research Council
- Janssen-Cilag Pty Limited
- Eisai Pharmaceuticals
- Eli Lilly and Company
- GlaxoSmithKline
- H Lundbeck A/S
- Medivation Inc.
- Novartis Pharmaceuticals
- Nutricia
- Pfizer Inc.
- Prana Biotechnology Limited
- Sanofi-Aventis
- Tau Rx
- Voyager Pharmaceutical Corporation
- Wyeth Limited
- Servier
- Forest
- Takeda
- Buck Institute
- Baxter
- bioCSL
- Prana Biotechnology
- Merck Sharp and Dohme
- Lundbeck
- Prana
- Pfizer
- Novartis
Ask authors/readers for more resources
Patients with dementia often require institutionalization when they can no longer care for themselves. The study examined demographic and clinical variables that predict the time until institutionalization in patients with dementia attending memory clinics. Of 970 patients recruited from nine memory clinics around Australia, 779 patients had dementia at baseline. Measures of dementia severity, cognition, functional ability, neuropsychiatric symptoms, caregiver burden, and medication use were completed for all patients. Patients were followed for three years. Overall, 197 (25.3%) of the patients with dementia were institutionalized within three years. Lower cognitive ability, lower functional ability, and more neuropsychiatric symptoms at baseline predicted a shorter time until institutionalization, as did use of antipsychotic medication. In addition, greater deterioration in cognitive ability, functional ability, and neuropsychiatric symptoms over the initial three months predicted a shorter time to institutionalization. The findings confirm that clinical features of dementia at baseline predict the time to institutionalization, as do greater changes in symptoms over three months independent of baseline levels.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available